Institute of Molecular Genetics of the Czech Academy of Sciences
| Project number: | TN02000020 |
| Provider: | Technology Agency of the Czech Republic |
| Beneficiary: | Institute of Scientific Instruments of the Czech Academy of Sciences |
| Project implementation: | 2023-2028 |
| Sub-project: | CAEPO – TN02000020/004N (NPO) |
Centre builds on the previous CEPO, unites key academic and industrial players in CR who are engaged in research in electron, photon and quantum technologies. CAEPO activities will enhance research excellence, application relevance of academic partners and knowledge transfer towards industrial partners focused on electron & light microscopy and spectroscopy, advanced lasers and their applications, opto-fiber sensors & probes, micro&nanostructured surfaces and optical elements, ultrasensitive detection at the edge of physical principles, ultra-precise production metrology and development of sophisticated elements and systems. This synergistic cooperation shifts the level of added value of CAEPO industrial partners outputs, brings 2/3 of them closer to and keeps 1/3 at level of world leaders.
| Project number: | TN02000122 |
| Provider: | Technology Agency of the Czech Republic |
| Beneficiary: | Palacký University Olomouc / Faculty of Medicine |
| Project implementation: | 2023-2028 |
| Sub-project: | TEREP – TN02000122/001N (NPO) |
Establishment of a centre of competence to achieve application potential in the field of recombinant drug preparation through the integration of research centres built within OP RDI/RDE. Building of research platform for the development of the Czech biotechnology and pharmaceutical industry and the renewal of the Institute of Sera and Vaccines. Development of recombinant proteins, molecular adjuvants, and carrier systems for the production of vaccines and therapeutics in treatment and prevention of infectious diseases, allergies, cerebrovascular and inflammatory diseases, and development of advanced analytical and diagnostic methods using nanomaterials. Development of a comprehensive mobile container system for vaccine production in emergencies (disasters, war operations, etc.).
| Project number: | TN02000132 |
| Provider: | Technology Agency of the Czech Republic |
| Beneficiary: | Institute of Molecular Genetics of the Czech Academy of Sciences |
| Project implementation: | 2023-2026 |
The DIAMOD project aims to improve diagnostic quality beyond the identification of mutations in the genome and to create a base for monitoring of disease progression and therapy effectiveness as well as for testing and development of cell and gene therapies. We intend to develop new analytic, monitoring and therapy tools products as follows: i) development of new analytic tools and technologies to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases development and treatment; development of AI approaches, ii) development and marketing of digital platform for better patient care, iii) development of humanized preclinical models to test cell/gene therapy, and iv) development of cell therapy based on NK cells.